Skip to content

Clinical Efficacy of OneTouch® Verio™IQ Meter

Clinical Efficacy of OneTouch® Verio™IQ Meter

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02521506
Acronym
ECOVIQ
Enrollment
90
Registered
2015-08-13
Start date
2015-03-31
Completion date
2016-12-31
Last updated
2017-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

Diabetes mellitus is one of the most prevalent disease in the western world. The control of glucose levels has a big impact in the prevention of diabetes complications. The measure of glucose levels in capillary blood with glucometers is the gold standard to measure and control the glucose levels. Nowadays the glucometers become to more precise and sophisticated devices. One of the most notables advance is the inclusion of software that cam predicts glucose trends. This software has not be tested in routine clinical practice.

Interventions

DEVICEVerio Pattern Alert® activated
DEVICEVerio Pattern Alert® deactivated

Sponsors

Fundación Pública Andaluza Progreso y Salud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patient diagnosed with diabetes mellitus 1 or 2 * Treatment with insulin regimen during at least 12 months * Capability of performed 3 glucose measurement per day * Levels of glycated hemoglobin (A1C) less than 10%

Exclusion criteria

* Patients diagnosed of mental disorders * Patients included in structured therapeutic health 6 months before the inclusion * Patients included in any clinical trial in the 4 months before the inclusion

Design outcomes

Primary

MeasureTime frameDescription
number of hypoglycemic events20 monthsGlucose levels under 70 mg/dL with or without clinical manifestation

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026